ArticleTherapeutic advances in medical oncology2024

Everolimus treatment in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer and a predictive model for its efficacy: a multicenter real-world study.

Yujing Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.